TY - JOUR T1 - COVID-19 in India: Predictions, Reproduction Number and Public Health Preparedness JF - medRxiv DO - 10.1101/2020.04.09.20059261 SP - 2020.04.09.20059261 AU - Balram Rai AU - Anandi Shukla AU - Laxmi Kant Dwivedi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/14/2020.04.09.20059261.abstract N2 - Introduction The COVID-19 has emerged as a global concern for public health due to large scale outbreak. The number of confirmed cases has also been increased in India in past few weeks. The predictions for the COVID-19 can provide insights into the epidemiology of the disease, which helps policymakers to check health system capacities.Methods We obtained data on daily confirmed, recovered and deaths cases for a period of 21 days and have implemented the exponential growth model to predict the future cases for all the three components. The mathematical model was used to calculate the average reproduction number and herd immunity. We estimated the number of active cases till 30th of April. We have also tried to analyze the public health capacity to combat COVID-19 in India.Results If the exponential growth in number of cases continue then the total number of active cases will be 2,49,635 until the end of April. The reproduction number for COVID-19 in India was found to be 2.56 and herd immunity as 61%. The cumulative cases predicted by the mathematical model was 1,20,203.Discussion This prediction provides an alarming situation for India in terms of public health preparedness. The number of tests is needed to increase to detect all the cases of COVID-19 in India. Though some serious preventive measures have been implemented, but India should be ready to face any sudden community outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData has been collected from the data-sharing portal www.covid19india.org for India. https://www.covid19india.org/ ER -